Cryptococcosis is a life-threatening fungal disease that usually presents as an opportunist infection in immunocompromised hosts, and Cryptococcus neoformans is the major opportunistic pathogen of cryptococcosis. Rapid diagnosis of C. neoformans and other opportunistic Cryptococcus pathogens is required to meet the clinical need for immediate treatment. Historically, negative staining with India ink has been used to identify Cryptococcus. Another staining method utilizes Alcian blue, a dye that reacts selectively with C. neoformans, but not other Cryptococcus species. To overcome these limitations, we developed a new staining method for rapid identification of Cryptococcus using a novel, patent pending staining reagent for clinical laboratory diagnosis. Cryptococci stained with this new reagent can be conveniently counted directly via bench-top light microscopy. We also compared our novel stain with India ink and Alcian blue. Our results demonstrated that the new staining technique was superior to India ink stain for the rapid identification of Cryptococcus in clinical (and clinically mimicking) samples. Our stable and cost-effective staining reagent specifically stained Cryptococcus, highlighting its clinical applicability, particularly in developing countries due to its low cost.
INTRODUCTION
Cryptococcosis or cryptococcal disease is a potentially fatal fungal disease that occurs in immunocompromised hosts due to an opportunist infection (Perfect and Casadevall, 2002; Gazzoni et al., 2009) . Cryptococcus neoformans and, somewhat less commonly, Cryptococcus gattii are the major opportunistic pathogens of this life-threatening disease as well as other human infections, including pulmonary infections and meningitis (Harding et al., 1979) . Cryptococcus species other than C. neoformans have long been generally regarded as nonpathogenic saprophytes. However, other Cryptococcus fungi species (example, Cryptococcus albidus, Cryptococcus curvatus, Cryptococcus humicolus, *Corresponding author. .
Cryptococcus uniguttulatus, and Cryptococcus laurentii)
have also been associated with opportunistic infections (Kamalam et al., 1977; Velez et al., 1996; Johnson et al., 1998; Kordossis et al., 1998; Ritterband et al., 1998; McCurdy and Morrow, 2001) .
Due to the wide spectrum of cryptococcosis and their opportunistic nature, rapid laboratory identification of Cryptococcus pathogens is needed to enable initiation of therapy without delay. Thus, in recent years, the need for rapid and accurate identification of Cryptococcus in the clinical laboratory setting has led to the development of many identification assays. Laboratory diagnosis of cryptococcosis includes conventional methods (example, direct microscopic examination and histopathology) (Gal et al., 1986; Perfect and Casadevall, 2002; Chayakulkeeree and Perfect, 2006; Gazzoni et al., 2008; 2009) that are usually associated with serology (Bloomfield et al., 1963; Berlin and Pincus, 1989; Leal et al., 2008) and isolation of the offending organism in culture (Berlin and Pincus, 1989; Perfect and Casadevall, 2002; Bovers et al., 2008) .
While a final diagnosis can ultimately be confirmed through a culture of the organism, the urgency to initiate treatment quickly requires that a presumptive diagnosis be made by direct examination of cerebrospinal fluid (CSF) and blood cultures. India ink stain testing has historically been used for this purpose, but India ink staining yields a positive result in only ~60% of cases of culture-proven infection (Butler et al., 1964) .
Microscopically, Cryptococcus yeast cells are spherical-to-oval in shape, 5 to 10 mm in diameter, and are surrounded by a polysaccharide capsule (Baker and Haugen, 1955) , which constitutes a major virulence factor and the substrate detected by cryptococcal antigen tests (CrAg) (Bloomfield et al., 1963) . However, capsuledeficient Cryptococcus infections may result in falsenegative results using this test (Harding et al., 1979; Monteil et al., 1997; Gazzoni et al., 2009 ). The rounded, large, "yeast-like" Cryptococcus cells can be counted directly with a blood cell counter.
However, it can be difficult to distinguish Cryptococcus cells from impurities, particulates, and white blood cells in unstained clinical samples (example, CSF). The Alcian blue stain method can also be used in the diagnosis of some types of cryptococcosis, such as salivary cryptococcosis in AIDS patients with disseminated C. neoformans infections (Monteil et al., 1997) . However, the Alcian blue method has very limited application in detection of other Cryptococcus fungi because the stain only reacts with the C. neoformans capsule (Lazcano et al., 1993) .
Here, we describe a new staining method for the rapid identification of Cryptococcus using a novel, patent pending staining reagent, namely Wan's staining reagent, which contains the commonly-used Evans blue dye. Cryptococcus staining with this cost-effective staining reagent enables convenient direct cell counting under a bench-top light microscope. We compared the staining results obtained using Wan's staining reagents relative to India ink and Alcian blue staining.
MATERIALS AND METHODS

Staining reagents
Wan's staining reagent, named after its inventor Dr. Ru-Gen Wan (the primary author of this article), was made by thoroughly mixing 1.0 g Evans blue dye (Direct Blue 53, Fluka, Switzerland) in a solution of 1.0 ml glacial acetic acid and 99.0 ml distilled water. The cost for each of these constituents was negligible. A complete Wan's staining reagent recipe has been filed for an invention patent in China (patent pending, application number: 200910154521.1). A 10 g/L working solution of Alcian blue staining reagent was made by thoroughly mixing 1.0 g Alcian blue (Chroma, Germany) in a solution of 1.0 ml glacial acetic acid and 99 ml distilled water. Ready-to-use India ink was purchased from Yidege Industry and Trade Center (Beijing, China). 
Instruments
Specimens were examined using an Olympus micro-diagnosis system (Olympus BX 51, Japan).
Specificity and stability of Wan's staining reagent
Sample preparation A was produced by mixing human white blood cells with Cryptococcus and Candida in 2 ml physiological saline to obtain suspended samples. Sample preparation B was produced by individually mixing Cryptococcus with each of the aforementioned fungi strains to obtain mixed samples. The above-described samples were each stained with Wan's staining reagent by mixing 50 µl of each sample with 50 µl of stain solution. For microscopic observation, the stained samples were placed on slides, covered with a cover slip, examined under 5 dca microscope with a 40× and 100× objective, and then examined further under an oil immersion (100×) objective to evaluate the specificity of Wan's staining reagent.
To test the stability of Wan's staining reagent, the staining results obtained using Wan's staining reagent stored at room temperature for 1 year, 6 months, or 1 month or freshly made on the day of testing were assessed. To assess the staining stability of the Wan's staining method, staining was evaluated after various durations (1, 5, 30, and 60 min) of staining.
Clinical application of Wan's staining reagent
A total of 73 CSF specimens collected from encephalitis patients, 11 lavage fluid specimens collected from patients with a lower respiratory infection, and 3 blood cultures were used in this study. These clinical samples were stained with either Wan's staining reagent or India ink to identify Cryptococcus fungi. If Cryptococcus was detected in the clinical samples, the fungal cells were counted manually using a blood cell counter. Cultured Cryptococcus aliquots from CSF were diluted to three different concentration ranges (10 to 20, 100 to 200, and 1000 to 2000 cells/µl) to obtain 10 samples that mimic clinical samples. These 10 samples were then coded and examined by 10 laboratory technicians (three senior, four mid-level, and three junior technicians) blinded to the sample identities. Three replicates of each sample were stained with Wan's staining reagent, Alcian blue, and India ink and then examined. We then counted the numbers of stained cells using a blood cell counter and compared the counting precision of Cryptococcal cells stained with Wan's reagent versus cells stained with Alcian blue. 
RESULTS
Staining clinically common fungi with Wan's staining reagent
Clinically common Cryptococcus species or mixtures of Cryptococcus and other clinically common Candida species were simultaneously stained with Wan's staining reagent to investigate the reagent's specificity. Typical staining results are shown in Figure 1 . C. albidus ( Figure  1A ) and C. laurentii (not shown) from clinical isolates and quality control C. neoformans ( Figure 1B ) and C. laurentii ( Figure 1C ) strains were stained blue or dark blue, while white blood cells and common Candida fungi [example, C glabrata ( Figure 1B) , C. tropicalis ( Figure 1C) ] were unstained. It should be noted that C. rugosa fungi were also stained, but the staining affected <1% of these cells. Therefore, stained cryptococcal cells were clearly distinguishable from clinically common Candida fungi, highlighting the high specificity of Wan's staining reagent for cryptococcal fungi.
Staining stability of Wan's staining reagent
The staining stability of Wan's staining reagent for mixtures of Cryptococcus and Candida fungi was compared after various durations (1, 5, 30, and 60 min) of staining.
Cryptococcus fungi were stained in as quickly as 1 min with Wan's staining reagent, while Candida fungi remained unstained (Figure 2A ). Wan's staining reagent demonstrated high-quality staining stability as excellent staining results were maintained for up to 1 h of staining ( Figures 2B to D) .
Stability of Wan's staining reagent
Wan's staining reagent proved to be very stable as stained cryptococcal cells were still clearly distinguishable from Candida fungi after simultaneously staining with Wan's stain that had been stored at room temperature for up to 1 year ( Figures 3A to D) .
Clinical application of Wan's staining reagent
We further evaluated the potential clinical application of Wan's reagent for the rapid identification of Cryptococcus in clinical samples. As a comparison, the traditional India ink staining method was used to stain clinical specimens or samples mimicking clinical specimens. CSF, lavage fluid, and blood culture samples were stained with Wan's staining reagent or India ink to identify Cryptococcus fungi. Cryptococcal cells were detected in 3/73 CSF specimens and 3/3 blood culture samples. No Cryptococcus fungi were identified in any of the 11 lavage fluid specimens. Like Wan's staining reagent, Alcian blue also stained Cryptococcus fungi. However, Alcian blue often also caused aggregation of the cryptococcal cells, particularly when handled by less experienced laboratory technicians. A high background of India ink staining could make false negative staining a problem when only a limited amount of Cryptococcus fungal cells with a small capsular size are present. In contrast, cryptococcal cells stained with Wan's reagent appeared blue with bright capsules on a clear background without any aggregation. Typical staining results for clinical samples using the three staining methods are shown in Figures 4A to C. When we compared the false negative rates of our new staining method with India ink staining for the 10 mock clinical samples, we observed a lower false negative rate for Wan's reagent than for India ink staining. Indeed, only three false negatives (3/100) occurred with Wan's reagent, and these occurred exclusively at low concentrations of cryptococcal cells (10 to 20 cells/µl). Conventional India ink staining resulted in a higher , and 2 × 10 cells/ l). Lower mean cell count values were consistently reported with Alcian blue stain due to the higher false negative rate of Alcian blue staining (described earlier). The cell count results are summarized in Table 1 . 
Staining effects of Wan's reagent for cryptococcal cells at high magnification
We further compared the staining effects of Wan's reagent and India ink staining for cryptococcal cells at high magnification. reagent was consistently superior to India ink for staining cryptococcal cells, even when examined at high magnification (compare Figure 6A vs. 6B). The intracellular structures of cryptococcal cells stained with Wan's reagent were clearly visible as bright capsules against a clear background ( Figure 6B ). India ink staining tended to mask cryptococcal cells, particularly small cells, resulting in false negative detections. In contrast, cells stained with Wan's reagent were clearly visible, regardless of size (compare Figure 6C vs. 6D). Thus, Wan's staining enhanced the positive detection rate.
DISCUSSION
In the present study, we report the testing of The Cryptococcus cell wall contains melanin, which may affect its porosity (Gomez and Nosanchuk, 2003; Jacobson and Ikeda, 2005) ; high porosity allows charged small-molecular dyes to permeate into cryptococcal cells. The staining mechanism of Wan's reagent may be Each result is the mean of three observations. CV: coefficient of variation. related to this permeability, but further studies are needed to elucidate the exact mechanism.
Conclusion
We 
